Navigation Links
National Institutes of Health grant to fund drug abuse research at UH
Date:11/28/2007

A center dedicated to building the multidisciplinary drug abuse research capacity of the University of Houston is the focus of a five-year, $2.3 million grant awarded to the Graduate College of Social Works Office of Drug and Social Policy Research (ODSPR).

Funding for the initiative comes from the National Institute on Drug Abuse (NIDA), which is part of the National Institutes for Health (NIH). The funds will support the creation of the Minority Institutions Drug Abuse Research Development Program (DARDP) at UH.

The emphasis of the DARDP is to train and mentor faculty and graduate students on the health and social consequences of drug abuse among aging minority populations and address drug abuse prevention, intervention and service research, said Avelardo Valdez, director of the ODSPR and principal investigator of the initiative. The institute will address drug use within the context of other related social and health problems confronting aging Latino injecting heroin users, and will contribute to improving the health of this population in the Houston area.

Focusing on developing research projects, the DARDP will collaborate with the UH Graduate College of Social Work, the Office for Drug and Social Policy Research, the Department of Sociology and other drug treatment organizations in the Houston area. In addition, the grant will fund two studies on Latino heroin use, workshops, seminars and small grants for faculty and students, and establish a peer-review ad-hoc committee that will oversee drafts of publications of new investigators.

Substance abuse is a serious problem in the Latino community, Valdez said. There are serious health and social consequences, such as the spread of HIV/AIDS and other blood-borne pathogens. To minimize this, we need a better understanding of the addict and addiction. Our purpose is to build more knowledge and put that knowledge into practice.

A pair of studies will focus on the heroin use of aging Latino men in Houstons near Northside and East End communities, where, Valdez says, there is a high rate of heroin use among Latinos. The first will study 225 users and look into the consequences of the addiction on their lifes path, long-term health implications and community and family support. The second study will focus on the role social networks, such as family and peers, play in a lifetime of heroine use. Both studies will investigate current users, those who are in treatment and those who are not in treatment. The overall objective is to develop the capacity of UH faculty to compete for external funding, particularly at the NIH level.


'/>"/>

Contact: Marisa Ramirez
mrcannon@uh.edu
713-743-8152
University of Houston  
Source:Eurekalert

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
National Institutes of Health grant to fund drug abuse research at UH
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD is dual ... City. He is known for his distinguished expertise and experience in the diagnosis and ... sub-specialty training in treating renovascular disease and aortic aneurysm . He is known ...
(Date:5/24/2017)... ... May 24, 2017 , ... NucleusHealth ... interpretation, has received U.S. Food and Drug Administration (FDA) 510(k) clearance ... and secure cloud platform for medical image management. At the core is patented ...
(Date:5/24/2017)... ... 2017 , ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now ... a referral. Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take ... Patients no longer need to feel the esthetic effects of wires and brackets when ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... Policy Solutions is vehemently opposed to Donald Trump’s budget, “A New Foundation for ... that inspires fear, demonizes the poor, marginalizes underserved populations, undermines productivity, and destroys ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... Course II of the HP3 (High-Performance Periodontal Practice) continuing education (CE) series. As ... latest advancements in his field by attending numerous CE courses each year. His ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... , May 9, 2017  Semler Scientific, Inc. ... technology solutions to improve the clinical effectiveness and ... for the first quarter ended March 31, 2017. ... enable our customers to identify when preventive care ... before events like heart attacks or strokes occur," ...
(Date:5/6/2017)... --  Provista , a proven leader in the supply chain ... Jim Cunniff as the company,s new president and ... to Provista, including most recently serving as the president and ... . He assumed his new role with Provista on May ... Provista," says Jody Hatcher , president, Sourcing and Collaboration ...
(Date:5/4/2017)... MONTREAL , May 4, 2017  Fortuna Fix Inc. (" ... aiming to be the first to eliminate the need for ... autologous cells to treat neurodegenerative diseases. Fortuna ... ("SAB") with Professor Michael Fehlings , MD, PhD; Father ... Hack , MD, MPH; and Professor James Giordano , ...
Breaking Medicine Technology: